Enter Note Done
Go to previous page in this tab
Session
  • Presentation | General Poster Session - Sunday General Poster Session
  • General Poster Session
  • Share Icon
    Map Icon
    Bookmark Icon
  • 853-P - Efficacy and Safety of a Novel Dual GLP-1/GIP Receptor Agonist (HRS9531), in Obese Adults without Diabetes—Up to 52-Week Treatment [Board No. 853]
    • Schedule
    Notes
  • Location IconPoster Hall (Hall F1)
    151
    Set Timezone

L.Zhao: None. Y.Hui: None. X.Zhang: None. H.Chen: Employee; ; Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Y.Zuo: Employee; ; Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Y.Sun: Employee; ; Jiangsu Hengrui Pharmaceuticals Co., Ltd.. X.Li: None. D.Zhu: None. T.Pan: None. D.Wang: None. H.Ling: None. Y.Li: None. H.Cai: None. Z.Cheng: None. D.Liu: None.
Type
Main Session